Lacrimal drainage system stenosis associated with Trastuzumab emtansine (Kadcyla®, T-DM1) administration: a case report

Lacrimal drainage system stenosis associated with Trastuzumab emtansine (Kadcyla®, T-DM1) administration: a case report

Abstract Background Trastuzumab emtansine (Kadcyla®, T-DM1) is an antibody-drug conjugate used to treat HER2 (human epidermal growth factor receptor 2) overexpressing metastatic breast cancer. In this report, we present the first case of lacrimal drainage system stenosis identified after T-DM1 admin...

Full description

Bibliographic Details
Main Authors: Chung Young Kim, Namju Kim, Ho-Kyung Choung, Sang In Khwarg
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Trastuzumab emtansine
Kadcyla
Breast cancer
Nasolacrimal duct stenosis
Epiphora
Online Access:http://link.springer.com/article/10.1186/s12885-019-5986-5

Similar Items

Similar Items